Multiple atypical nevi: a cutaneous marker of germ cell tumors.

PURPOSE This study assessed whether a specific association exists between atypical nevi and germ cell tumors (GCT). METHODS A prospective comparison was performed on a cohort of 129 unselected patients with GCT and a series of 153 healthy men. Three or more of the following criteria were required for diagnosis of multiple atypical nevi: greater than 5 mm in diameter; variegated color, often speckled black/brown, with irregularly distributed pigmentation; irregular outline or indistinct border; and at least three such lesions. RESULTS Prevalences for multiple atypical nevi in patients with GCT and in healthy controls were 37% and 15%, respectively (P < .01). Two patients with these lesions also had documented malignant melanoma. In contrast, 16% of patients with GCT had a history of testicular maldescent (the most common known risk factor), compared with 5% of healthy controls (P < .01). CONCLUSION Multiple atypical nevi occur with a statistically significant increased prevalence in patients with GCT as compared with healthy controls, and constitute one of the most common known clinical associations with this malignancy. These data may be of relevance for our understanding of the biology of GCT and of malignant melanoma, in the design of screening programs for testis cancer, and in the follow-up evaluation of patients with each of these disorders.

[1]  J. Kirkwood,et al.  Homozygous deletions within human chromosome band 9p21 in melanoma. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[2]  V. Reuter,et al.  Cytogenetic analysis of 124 prospectively ascertained male germ cell tumors. , 1992, Cancer research.

[3]  D. Raghavan,et al.  Toxicity of treatment of germ cell tumors. , 1992, Seminars in oncology.

[4]  N. Hayward,et al.  Exclusion of the familial melanoma locus (MLM) from the PND/D1S47 and MYCL1 regions of chromosome arm 1p in 7 Australian pedigrees. , 1992, Genomics.

[5]  R. Kefford,et al.  Hereditary melanoma in Australia. Variable association with dysplastic nevi and absence of genetic linkage to chromosome 1p. , 1991, Cancer genetics and cytogenetics.

[6]  R. Lothe,et al.  Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy. , 1990, British Journal of Cancer.

[7]  N. Gruis,et al.  Locus for susceptibility to melanoma on chromosome 1p. , 1990, The New England journal of medicine.

[8]  D. Forman,et al.  Aetiology and epidemiology of testicular cancer: report of consensus group. , 1990, Progress in clinical and biological research.

[9]  J. Richie,et al.  Regional loss of chromosome 6 in two urological malignancies. , 1989, Cancer research.

[10]  P. Green,et al.  Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. , 1989, The New England journal of medicine.

[11]  U. Francke,et al.  Cytogenetic analysis of melanocytes from premalignant nevi and melanomas. , 1988, Journal of the National Cancer Institute.

[12]  F. Pelloni,et al.  Dysplastic nevi and germ cell tumors of the testis--a possible further tumor in the spectrum of associated malignancies in dysplastic nevus syndrome. , 1988, Dermatologica.

[13]  D. Stablein,et al.  Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. , 1987, The New England journal of medicine.

[14]  N. Day,et al.  Second malignancies following testicular cancer, ovarian cancer and hodgkin's disease: An international collaborative study among cancer registries , 1987, International journal of cancer.

[15]  D. English,et al.  The dysplastic naevus syndrome in patients with cutaneous malignant melanoma in Western Australia , 1986, The Medical journal of Australia.

[16]  W. Clark,et al.  Dysplastic nevus syndrome: A phenotypic association of sporadic cutaneous melanoma , 1980, Cancer.

[17]  T. Jelihovsky,et al.  Father‐son testicular malignancy does genetic anticipation occur? , 1980, Cancer.

[18]  W. Clark,et al.  Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'. , 1978, Archives of dermatology.